Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0025 Transporter Info | ||||
Gene Name | SLC22A8 | ||||
Transporter Name | Organic anion transporter 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC22A8 Modification Sites with Functional and Structural Information | |||||
Sequence |
MTFSEILDRV GSMGHFQFLH VAILGLPILN MANHNLLQIF TAATPVHHCR PPHNASTGPW
VLPMGPNGKP ERCLRFVHPP NASLPNDTQR AMEPCLDGWV YNSTKDSIVT EWDLVCNSNK LKEMAQSIFM AGILIGGLVL GDLSDRFGRR PILTCSYLLL AASGSGAAFS PTFPIYMVFR FLCGFGISGI TLSTVILNVE WVPTRMRAIM STALGYCYTF GQFILPGLAY AIPQWRWLQL TVSIPFFVFF LSSWWTPESI RWLVLSGKSS KALKILRRVA VFNGKKEEGE RLSLEELKLN LQKEISLAKA KYTASDLFRI PMLRRMTFCL SLAWFATGFA YYSLAMGVEE FGVNLYILQI IFGGVDVPAK FITILSLSYL GRHTTQAAAL LLAGGAILAL TFVPLDLQTV RTVLAVFGKG CLSSSFSCLF LYTSELYPTV IRQTGMGVSN LWTRVGSMVS PLVKITGEVQ PFIPNIIYGI TALLGGSAAL FLPETLNQPL PETIEDLENW SLRAKKPKQE PEVEKASQRI PLQPHGPGLG SS |
||||
PTM type |
X-N-glycosylation
X-Phosphorylation
X-SUMOylation
X: Amino Acid
|
N-glycosylation |
|||||
---|---|---|---|---|---|
Asparagine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC22A8 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Asparagine |
Modified Location |
86 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
N-linked Glycosylation at SLC22A8 Asparagine 86 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC22A8 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Asparagine |
Modified Location |
102 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
N-linked Glycosylation at SLC22A8 Asparagine 102 has the potential to affect its expression or activity. | ||||
Phosphorylation |
|||||
Serine |
8 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Decreasing the activity of SLC22A8 | [2] | |||
Role of PTM |
Protein Activity Modulation | ||||
Affected Drug/Substrate |
Para-aminohippuric acid (PAH) |
Results for Drug |
Decreasing uptake of para-aminohippuric acid (PAH) | ||
Modified Residue |
Serine | ||||
Related Enzyme |
|||||
Experimental Material(s) |
Pig kidney epithelial (LLC-PK1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Serine have been reported to decrease its transport activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC22A8 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
4 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Serine 4 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC22A8 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
293 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Serine 293 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC22A8 | [4] , [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
315 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Serine 315 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 5 |
Have the potential to influence SLC22A8 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
460 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Serine 460 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 6 |
Have the potential to influence SLC22A8 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
511 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Serine 511 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 7 |
Have the potential to influence SLC22A8 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
541 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Serine 541 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 8 |
Have the potential to influence SLC22A8 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
542 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Serine 542 has the potential to affect its expression or activity. | ||||
Threonine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC22A8 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
2 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Threonine 2 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC22A8 | [4] , [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
313 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Threonine 313 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC22A8 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
373 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Threonine 373 has the potential to affect its expression or activity. | ||||
Tyrosine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC22A8 | [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
312 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 Tyrosine 312 has the potential to affect its expression or activity. | ||||
Unclear Residue |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Enhancing the expression and transport activity SLC22A8 | [8] | |||
Role of PTM |
Protein Activity Modulation | ||||
Related Enzyme |
|||||
Experimental Material(s) |
African green monkey kidney fibroblast-like (COS-7) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC22A8 have been reported to enhance its expression and transport activity. | ||||
SUMOylation |
|||||
Lysine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Enhancing the recycling rate and transport activity SLC22A8 | [9] | |||
Role of PTM |
Protein Activity Modulation | ||||
Modified Residue |
Lysine | ||||
Related Enzyme |
|||||
Experimental Material(s) |
African green monkey kidney fibroblast-like (COS-7) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
SUMOylation at SLC22A8 Lysine have been reported to enhance its recycling rate and transport activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.